The Sarcoma Alliance is deeply grateful for the continuing support for our work by the following corporations.
In July 2013 Threshold gave the Sarcoma Alliance a grant for $5,000 to support our efforts on our website to update our clinical trials information.
Brush Dance develops products that combine powerful and playful words and images that act as daily reminders, that inspire, connect, challenge, and support. In the near future they will be selling a line of holiday greeting cards with the proceeds donated to the Sarcoma Alliance.
Penni Gladstone helped us update our store, providing us with professionally shot images of our t-shirts, sunflower seeds, and other products. Penni is an award winning photojournalist and twice nominated for the Pulitzer. Her work has appeared in The New York Times, Fortune, Time, Marie Claire. Penni is available for corporate shoots, family portraits, and special events. Penni can be reached at Penni@PenniGladstone.com or by telephone at (415) 706-6960.
EMD Serono is the biopharmaceutical subsidiary of Merck KGaA, Darmstadt,
Germany, a global pharmaceutical and chemical group. They strive to create value and benefit patients by transforming medical science into breakthrough solutions in their core therapeutic areas of neurodegenerative diseases, fertility and metabolic endocrinology, as well as oncology and autoimmune/inflammatory diseases as emerging areas of expertise.
The Comedy and Magic Club has supported the Ocean of Hope Campaign by donating VIP tickets to our raffle. Located in Hermosa Beach, CA the club hosts local and internationally famous comedians and magicians including regular appearances by Jay Leno.
E&B Natural Resources is an independent oil and natural gas production company with strong roots in California, and wide experience in implementing advanced resource recovery technology within urban environments.
For the past few years Fujifilm has generously provided in-kind support for photography services at our Ocean of Hope event in Manhattan Beach.
Joe Bark, the premier designer and maker of paddleboards, has generously provided paddleboards for our raffle during the Ocean of Hope campaign. He has been a long time supporter and for those who have seen his board know that they are not only functional (used by all the top paddleboarders) but are works are art.
Since 1994, Jol Design been providing state-of-the-art design, screenmaking, and screenprinting production services to major film studios, five-star dining establishments, large corporations, schools, clubs, events and numerous surf and skate companies.
KonaRed Corporation develops wellness beverages and powders made from Hawaiian CoffeeBerry ®.
Its products are sold in select Whole Foods, Safeway, Sprouts, 7-Eleven, and many other retail outlets throughout the U.S. and Canada.
On It Pro, located in Ventura, California is owned and operated by avid surfers and watermen. Its provides innovative and high tech products to the extreme sports market. All of its products use space aged exotic materials and have been tested under the extreme conditions of the high performance marine industry.
Samy’s Camera has donated film processing and printing as well a CDs of all pictures taken at the Catalina Classic.
Zinka is the original action sports sunscreen company, credited with introducing the first ever colored zinc oxide sunblock. Zinka offers a wide range of broad spectrum UVA and UVB blocking products that are safe for all ages, as well as endorsed by Dermatologists, professional athletes and outdoor enthusiasts worldwide!
Ariad provided support for the Peer to Peer Program with four grants to get the program up and running. Since that time almost 1,000people from all 50 states and from over 20 countries have signed up. We continue to receive feedback on how valuable this program is and thank Ariad for its generosity.
In January 2011 Genentech awarded a $15,000 grant to make improvements to our website. We will be implementing a new chat room that will allow us to fully moderate guest experts, make some functional changes to our Peer to Peer program, add a new caregiver section, and to update and reorganize existing content on our website. In 2008 Genentech provided generous support that made major changes to our website and the programs and services it supports.
In January 2012, Merck gave the Sarcoma Alliance $15,000 to enhance its Peer to Peer Program. These funds will be used to develop a brochure for the program and to make much needed software improvements to the administration of the program. This will greatly increase staff efficiency and make the job of finding optimal matches much easier.
Pfizer has been a supporter of our Ocean of Hope campaign underwriting some of our expenses.
ZIOPHARM Oncology awarded a $10,000 grant in January 2013 in support of the Sarcoma Alliance Assistance Fund program. This follows grants of $10,000 in 2012 and $5,000 in 2011. The grant will help support program costs and allow us to continue outreach activities. Ziopharm is a biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of cancer therapeutics. The Company is currently focused on several clinical programs.
Darinaparsin (Zinapar(tm) or ZIO-101) is a novel mitochondrial-targeted agent (organic arsenic) being developed intravenously for the treatment of relapsed peripheral T-cell lymphoma likely with a two-stage potentially pivotal study expected to begin in late 2011. An oral form is in a Phase I trial in solid tumors.
Indibulin (Zybulin(tm) or ZIO-301) is a novel, oral tubulin binding agent that is expected to have several potential benefits including oral dosing, application in multi-drug resistant tumors, no neuropathy and a quite tolerable toxicity profile. It is currently being studied in Phase I/II in metastatic breast cancer.
ZIOPHARM is also pursuing the development of novel DNA-based therapeutics in the field of cancer pursuant to an exclusive channel partnership with Intrexon Corporation. The partnership includes two existing clinical-stage product candidates, the first of which is in a Phase Ib study and the second entering Phase I study.
ZIOPHARM’s operations are located in Boston, MA and Germantown, MD with an executive office in New York City. Further information about ZIOPHARM may be found at http://www.ziopharm.com.